These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 39211288)

  • 21. Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint.
    Wu ZH; Li N; Mei XF; Chen J; Wang XZ; Guo TT; Chen G; Nie L; Chen Y; Jiang MZ; Wang JT; Wang HB
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35256517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?
    Beizavi Z; Gheibihayat SM; Moghadasian H; Zare H; Yeganeh BS; Askari H; Vakili S; Tajbakhsh A; Savardashtaki A
    Mol Biol Rep; 2021 Jul; 48(7):5707-5722. PubMed ID: 34275112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal regulatory protein alpha blockade potentiates tumoricidal effects of macrophages on gastroenterological neoplastic cells in syngeneic immunocompetent mice.
    Abe T; Tanaka Y; Piao J; Tanimine N; Oue N; Hinoi T; Garcia NV; Miyasaka M; Matozaki T; Yasui W; Ohdan H
    Ann Gastroenterol Surg; 2018 Nov; 2(6):451-462. PubMed ID: 30460349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes.
    Gitik M; Liraz-Zaltsman S; Oldenborg PA; Reichert F; Rotshenker S
    J Neuroinflammation; 2011 Mar; 8():24. PubMed ID: 21401967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.
    Voets E; Paradé M; Lutje Hulsik D; Spijkers S; Janssen W; Rens J; Reinieren-Beeren I; van den Tillaart G; van Duijnhoven S; Driessen L; Habraken M; van Zandvoort P; Kreijtz J; Vink P; van Elsas A; van Eenennaam H
    J Immunother Cancer; 2019 Dec; 7(1):340. PubMed ID: 31801627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CD47-SIRPα axis is a promising target for cancer immunotherapies.
    Hao Y; Zhou X; Li Y; Li B; Cheng L
    Int Immunopharmacol; 2023 Jul; 120():110255. PubMed ID: 37187126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis.
    Fenyo IM; Gafencu AV
    Immunobiology; 2013 Nov; 218(11):1376-84. PubMed ID: 23886694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.
    Jin S; Wang H; Li Y; Yang J; Li B; Shi P; Zhang X; Zhou X; Zhou X; Niu X; Wu M; Wu Y; Zhai W; Qi Y; Gao Y; Zhao W
    Cell Commun Signal; 2024 Mar; 22(1):173. PubMed ID: 38462636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered
    VandenHeuvel SN; Chau E; Mohapatra A; Dabbiru S; Roy S; O'Connell C; Kamat A; Godin B; Raghavan SA
    ACS Appl Bio Mater; 2024 Dec; 7(12):7871-7882. PubMed ID: 38558434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells.
    Tahk S; Vick B; Hiller B; Schmitt S; Marcinek A; Perini ED; Leutbecher A; Augsberger C; Reischer A; Tast B; Humpe A; Jeremias I; Subklewe M; Fenn NC; Hopfner KP
    J Hematol Oncol; 2021 Sep; 14(1):155. PubMed ID: 34579739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD47-SIRPα Checkpoint Disruption in Metastases Requires Tumor-Targeting Antibody for Molecular and Engineered Macrophage Therapies.
    Andrechak JC; Dooling LJ; Tobin MP; Zhang W; Hayes BH; Lee JY; Jin X; Irianto J; Discher DE
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of RIG-I/MDA5 Signaling and Inhibition of CD47-SIRPα Checkpoint with a Dual siRNA-Assembled Nanoadjuvant for Robust Cancer Immunotherapy.
    Xu X; Li S; Yu W; Yao S; Fan H; Guo Z
    Angew Chem Int Ed Engl; 2024 Mar; 63(10):e202318544. PubMed ID: 38194267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CD47-SIRPα signalling system: its physiological roles and therapeutic application.
    Murata Y; Kotani T; Ohnishi H; Matozaki T
    J Biochem; 2014 Jun; 155(6):335-44. PubMed ID: 24627525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axis.
    Chen XJ; Guo CH; Wang ZC; Yang Y; Pan YH; Liang JY; Sun MG; Fan LS; Liang L; Wang W
    Cell Commun Signal; 2024 Jan; 22(1):15. PubMed ID: 38183060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection.
    Torzewski M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD47/SIRPα axis: bridging innate and adaptive immunity.
    van Duijn A; Van der Burg SH; Scheeren FA
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35831032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular and extracellular synergistic therapy for restoring macrophage functions via anti-CD47 antibody-conjugated bifunctional nanoparticles in atherosclerosis.
    Luo Q; Dai L; Li J; Chen H; Hao Y; Li Q; Pan L; Song C; Qian Z; Chen M
    Bioact Mater; 2024 Apr; 34():326-337. PubMed ID: 38274294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation.
    Badrnya S; Schrottmaier WC; Kral JB; Yaiw KC; Volf I; Schabbauer G; Söderberg-Nauclér C; Assinger A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):571-80. PubMed ID: 24371083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sonodynamic Therapy Promotes Efferocytosis via CD47 Down-Regulation in Advanced Atherosclerotic Plaque.
    Cao Y; Yao J; Gao W; Cao Z; Diabakte K; Wang L; Sun X; Tian Y
    Int Heart J; 2022 Jan; 63(1):131-140. PubMed ID: 35034916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.